ACET Adicet Bio, Inc.

Adicet Bio, Inc. is a biotechnology company discovering and developing allogeneic gamma delta T cells therapies for cancer and other diseases.

$9.44  -0.84 (-8.17%)
As of 06/22/2021 15:59:57 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Other
Index country:  USA
Country of incorporation:  USA
IPO date:  01/26/2018
Outstanding shares:  31,813,542
Average volume:  140,245
Market cap:   $335,314,733
Current dividend yield:  7.43%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    007002108
ISIN:        US0070021086
Sedol:      BMC5RV6
Valuation   (See tab for details)
PE ratio:   -7.26
PB ratio:   1.38
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy